Aprea TherapeuticsAPRE
13F holders, Q1 2024 (March 31)2holders
$6.68avg. 13F price*
At the end of Q1 2024, 2 institutions reported holding Aprea Therapeutics Inc. (APRE) in their 13F filings. The largest holders were Lanark Financial, Inc. ($6K) and Princeton Global Asset Management LLC ($669).
- Company
- Aprea Therapeutics Inc.
- CUSIP
- 03836J102
- Latest filing quarter
- Q3 2024
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $6K |
| Exits | 0 | $0 |
Ownership 2 holders
| Lanark Financial, Inc. | 0.00% | New | 899 | $6K |
| Princeton Global Asset Management LLC | 0.00% | No change | 100 | $669 |
"% of holder's portfolio" is APRE's weight in each manager's 13F, not the share of Aprea Therapeutics Inc. the manager owns.